Evidence map›Paper›PMID 36194041›Full record

ArticleThe Journal of clinical endocrinology and metabolism2022

Appropriate Use of Telehealth Visits in Endocrinology: Policy Perspective of the Endocrine Society.

Varsha G Vimalananda, Juan P Brito, Leslie A Eiland, Rayhan A Lal, Spyridoula Maraka, Marie E McDonnell, Radhika R Narla, Mara Y Roth, Stephanie S Crossen

Abstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Telemedicine Visit Use and Glycemic Control in Patients With Diabetes.The Journal of clinical endocrinology and metabolism · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Tele-Oncology Use During the COVID-19 Pandemic: Patient Experiences and Communication Behaviors with Clinicians.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Varsha G VimalanandaCenter for Healthcare Organization and Implementation Research, VA Bedford Healthcare System, Bedford, Massachusetts 01730, USA.ORCID 0000-0003-0738-672X
Juan P BritoKnowledge and Evaluation Research (KER) Unit, Mayo Clinic, Rochester, Minnesota, USA.
Leslie A EilandDivision of Diabetes, Endocrinology & Metabolism, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Rayhan A LalDivision of Endocrinology, Department of Medicine, Stanford University, Stanford, California, USA.
Spyridoula MarakaKnowledge and Evaluation Research (KER) Unit, Mayo Clinic, Rochester, Minnesota, USA.
Marie E McDonnellDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-2263-9783
Radhika R NarlaDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, USA.
Mara Y RothDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, USA.
Stephanie S CrossenDivision of Endocrinology, Department of Pediatrics, University of California Davis School of Medicine, Sacramento, California, USA.

Funding

De-implementation of inappropriate thyroid ultrasoundR37CA272473 · NCI · MAYO CLINIC ROCHESTER · PI Juan P Brito Campana · 2022 to 2026
$2.6M
The Optimal Pathway to Implanted Autonomous Insulin DeliveryK23DK122017 · NIDDK · STANFORD UNIVERSITY · PI LAL, RAYHAN · 2020 to 2024
$958k
Use of connected health technology to optimize outcomes for high risk pediatric patients with type 1 diabetesK23DK125671 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CROSSEN, STEPHANIE · 2020 to 2023
$649k
Lilly, Inc.NCI NIH HHS R37 CA272473NIDDK NIH HHS K23 DK122017NIDDK NIH HHS K23 DK125671
6 · The paper itself

Abstract

objectiveThis work aims to guide clinicians practicing endocrinology in the use of telehealth (synchronous patient-clinician visits conducted over video or telephone) for outpatient care.

participantsThe Endocrine Society convened a 9-member panel of US endocrinologists with expertise in telehealth clinical care, telehealth operations, patient-centered care, health care delivery research, and/or evidence-based medicine. EVIDENCE: The panel conducted a literature search to identify studies published since 2000 about telehealth in endocrinology. One member extracted a list of factors affecting the quality of endocrine care via telehealth from the extant literature. The panel grouped these factors into 5 domains: clinical, patient, patient-clinician relationship, clinician, and health care setting and technology. CONSENSUS PROCESS: For each domain, 2 or 3 members drew on existing literature and their expert opinions to draft a section examining the effect of the domain's component factors on the appropriateness of telehealth use within endocrine practice. Appropriateness was evaluated in the context of the 6 Institute of Medicine aims for health care quality: patient-centeredness, equity, safety, effectiveness, timeliness, and efficiency. The panel held monthly virtual meetings to discuss and revise each domain. Two members wrote the remaining sections and integrated them with the domains to create the full policy perspective, which was reviewed and revised by all members.

conclusionsTelehealth has become a common care modality within endocrinology. This policy perspective summarizes the factors determining telehealth appropriateness in various patient care scenarios. Strategies to increase the quality of telehealth care are offered. More research is needed to develop a robust evidence base for future guideline development.

Indexed as

EndocrinologyTelemedicineAmbulatory CareEvidence-Based MedicineHumansPolicyconsensus statementendocrinologyguidelinespolicy perspectivetelehealthtelemedicinevirtual care

Identifiers

PMID36194041
PMCPMC10233476

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.